{"id":174333,"date":"2024-07-23T17:30:27","date_gmt":"2024-07-23T10:30:27","guid":{"rendered":"https:\/\/www.nstda.or.th\/openarchive\/?post_type=tnc_col_2494_item&#038;p=174333"},"modified":"2024-07-26T09:09:16","modified_gmt":"2024-07-26T02:09:16","slug":"immunogenicity-of-a-fractional-or-full-third-dose-of-azd1222-vaccine-or-bnt162b2-messenger-rna-vaccine-after-two-doses-of-coronavac-vaccines-against-the-delta-and-omicron-variants","status":"publish","type":"tnc_col_2494_item","link":"https:\/\/www.nstda.or.th\/openarchive\/nstda-research-publications\/immunogenicity-of-a-fractional-or-full-third-dose-of-azd1222-vaccine-or-bnt162b2-messenger-rna-vaccine-after-two-doses-of-coronavac-vaccines-against-the-delta-and-omicron-variants\/","title":{"rendered":"Immunogenicity of a fractional or full third dose of AZD1222 vaccine or BNT162b2 messenger RNA vaccine after two doses of CoronaVac vaccines against the Delta and Omicron variants"},"content":{"rendered":"","protected":false},"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","format":"standard","class_list":["post-174333","tnc_col_2494_item","type-tnc_col_2494_item","status-publish","format-standard","hentry","tnc_tax_11166-applied-microbiology","tnc_tax_11164-microbiology","tnc_tax_11162-biological-science","tnc_tax_11156-n-a","tnc_tax_2222-booster-strategy","tnc_tax_2222-covid-19","tnc_tax_2222-immune-response","tnc_tax_2222-vaccine"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Immunogenicity of a fractional or full third dose of AZD1222 vaccine or BNT162b2 messenger RNA vaccine after two doses of CoronaVac vaccines against the Delta and Omicron variants - NSTDA Open Repository<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.nstda.or.th\/openarchive\/nstda-research-publications\/immunogenicity-of-a-fractional-or-full-third-dose-of-azd1222-vaccine-or-bnt162b2-messenger-rna-vaccine-after-two-doses-of-coronavac-vaccines-against-the-delta-and-omicron-variants\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Immunogenicity of a fractional or full third dose of AZD1222 vaccine or BNT162b2 messenger RNA vaccine after two doses of CoronaVac vaccines against the Delta and Omicron variants - NSTDA Open Repository\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.nstda.or.th\/openarchive\/nstda-research-publications\/immunogenicity-of-a-fractional-or-full-third-dose-of-azd1222-vaccine-or-bnt162b2-messenger-rna-vaccine-after-two-doses-of-coronavac-vaccines-against-the-delta-and-omicron-variants\/\" \/>\n<meta property=\"og:site_name\" content=\"NSTDA Open Repository\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-26T02:09:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.nstda.or.th\/openarchive\/wp-content\/uploads\/2019\/02\/cropped-cropped-aw-nstda-color-1-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"2000\" \/>\n\t<meta property=\"og:image:height\" content=\"625\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.nstda.or.th\/openarchive\/nstda-research-publications\/immunogenicity-of-a-fractional-or-full-third-dose-of-azd1222-vaccine-or-bnt162b2-messenger-rna-vaccine-after-two-doses-of-coronavac-vaccines-against-the-delta-and-omicron-variants\/\",\"url\":\"https:\/\/www.nstda.or.th\/openarchive\/nstda-research-publications\/immunogenicity-of-a-fractional-or-full-third-dose-of-azd1222-vaccine-or-bnt162b2-messenger-rna-vaccine-after-two-doses-of-coronavac-vaccines-against-the-delta-and-omicron-variants\/\",\"name\":\"Immunogenicity of a fractional or full third dose of AZD1222 vaccine or BNT162b2 messenger RNA vaccine after two doses of CoronaVac vaccines against the Delta and Omicron variants - NSTDA Open Repository\",\"isPartOf\":{\"@id\":\"https:\/\/www.nstda.or.th\/openarchive\/#website\"},\"datePublished\":\"2024-07-23T10:30:27+00:00\",\"dateModified\":\"2024-07-26T02:09:16+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.nstda.or.th\/openarchive\/nstda-research-publications\/immunogenicity-of-a-fractional-or-full-third-dose-of-azd1222-vaccine-or-bnt162b2-messenger-rna-vaccine-after-two-doses-of-coronavac-vaccines-against-the-delta-and-omicron-variants\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.nstda.or.th\/openarchive\/nstda-research-publications\/immunogenicity-of-a-fractional-or-full-third-dose-of-azd1222-vaccine-or-bnt162b2-messenger-rna-vaccine-after-two-doses-of-coronavac-vaccines-against-the-delta-and-omicron-variants\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.nstda.or.th\/openarchive\/nstda-research-publications\/immunogenicity-of-a-fractional-or-full-third-dose-of-azd1222-vaccine-or-bnt162b2-messenger-rna-vaccine-after-two-doses-of-coronavac-vaccines-against-the-delta-and-omicron-variants\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.nstda.or.th\/openarchive\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NSTDA's Research Publications\",\"item\":\"https:\/\/www.nstda.or.th\/openarchive\/nstda-research-publications\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Immunogenicity of a fractional or full third dose of AZD1222 vaccine or BNT162b2 messenger RNA vaccine after two doses of CoronaVac vaccines against the Delta and Omicron variants\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.nstda.or.th\/openarchive\/#website\",\"url\":\"https:\/\/www.nstda.or.th\/openarchive\/\",\"name\":\"NSTDA Open Repository\",\"description\":\"NSTDA Open Repository is a digital open-access repository for NSTDA&#039;s research publications, including manuscripts, journal articles conference papers, reviews, and more. The publications are made available in the Repository on terms of Creative Commons License. You may read, download, share, and re-use for your research as long as you abide by the license under which an item has been released.\",\"publisher\":{\"@id\":\"https:\/\/www.nstda.or.th\/openarchive\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.nstda.or.th\/openarchive\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.nstda.or.th\/openarchive\/#organization\",\"name\":\"National Science and Technology Development Agency\",\"url\":\"https:\/\/www.nstda.or.th\/openarchive\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.nstda.or.th\/openarchive\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/www.nstda.or.th\/openarchive\/wp-content\/uploads\/2019\/02\/cropped-cropped-aw-nstda-color-1-1.png\",\"contentUrl\":\"http:\/\/www.nstda.or.th\/openarchive\/wp-content\/uploads\/2019\/02\/cropped-cropped-aw-nstda-color-1-1.png\",\"width\":2000,\"height\":625,\"caption\":\"National Science and Technology Development Agency\"},\"image\":{\"@id\":\"https:\/\/www.nstda.or.th\/openarchive\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Immunogenicity of a fractional or full third dose of AZD1222 vaccine or BNT162b2 messenger RNA vaccine after two doses of CoronaVac vaccines against the Delta and Omicron variants - NSTDA Open Repository","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.nstda.or.th\/openarchive\/nstda-research-publications\/immunogenicity-of-a-fractional-or-full-third-dose-of-azd1222-vaccine-or-bnt162b2-messenger-rna-vaccine-after-two-doses-of-coronavac-vaccines-against-the-delta-and-omicron-variants\/","og_locale":"en_US","og_type":"article","og_title":"Immunogenicity of a fractional or full third dose of AZD1222 vaccine or BNT162b2 messenger RNA vaccine after two doses of CoronaVac vaccines against the Delta and Omicron variants - NSTDA Open Repository","og_url":"https:\/\/www.nstda.or.th\/openarchive\/nstda-research-publications\/immunogenicity-of-a-fractional-or-full-third-dose-of-azd1222-vaccine-or-bnt162b2-messenger-rna-vaccine-after-two-doses-of-coronavac-vaccines-against-the-delta-and-omicron-variants\/","og_site_name":"NSTDA Open Repository","article_modified_time":"2024-07-26T02:09:16+00:00","og_image":[{"width":2000,"height":625,"url":"https:\/\/www.nstda.or.th\/openarchive\/wp-content\/uploads\/2019\/02\/cropped-cropped-aw-nstda-color-1-1.png","type":"image\/png"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.nstda.or.th\/openarchive\/nstda-research-publications\/immunogenicity-of-a-fractional-or-full-third-dose-of-azd1222-vaccine-or-bnt162b2-messenger-rna-vaccine-after-two-doses-of-coronavac-vaccines-against-the-delta-and-omicron-variants\/","url":"https:\/\/www.nstda.or.th\/openarchive\/nstda-research-publications\/immunogenicity-of-a-fractional-or-full-third-dose-of-azd1222-vaccine-or-bnt162b2-messenger-rna-vaccine-after-two-doses-of-coronavac-vaccines-against-the-delta-and-omicron-variants\/","name":"Immunogenicity of a fractional or full third dose of AZD1222 vaccine or BNT162b2 messenger RNA vaccine after two doses of CoronaVac vaccines against the Delta and Omicron variants - NSTDA Open Repository","isPartOf":{"@id":"https:\/\/www.nstda.or.th\/openarchive\/#website"},"datePublished":"2024-07-23T10:30:27+00:00","dateModified":"2024-07-26T02:09:16+00:00","breadcrumb":{"@id":"https:\/\/www.nstda.or.th\/openarchive\/nstda-research-publications\/immunogenicity-of-a-fractional-or-full-third-dose-of-azd1222-vaccine-or-bnt162b2-messenger-rna-vaccine-after-two-doses-of-coronavac-vaccines-against-the-delta-and-omicron-variants\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.nstda.or.th\/openarchive\/nstda-research-publications\/immunogenicity-of-a-fractional-or-full-third-dose-of-azd1222-vaccine-or-bnt162b2-messenger-rna-vaccine-after-two-doses-of-coronavac-vaccines-against-the-delta-and-omicron-variants\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.nstda.or.th\/openarchive\/nstda-research-publications\/immunogenicity-of-a-fractional-or-full-third-dose-of-azd1222-vaccine-or-bnt162b2-messenger-rna-vaccine-after-two-doses-of-coronavac-vaccines-against-the-delta-and-omicron-variants\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.nstda.or.th\/openarchive\/"},{"@type":"ListItem","position":2,"name":"NSTDA's Research Publications","item":"https:\/\/www.nstda.or.th\/openarchive\/nstda-research-publications\/"},{"@type":"ListItem","position":3,"name":"Immunogenicity of a fractional or full third dose of AZD1222 vaccine or BNT162b2 messenger RNA vaccine after two doses of CoronaVac vaccines against the Delta and Omicron variants"}]},{"@type":"WebSite","@id":"https:\/\/www.nstda.or.th\/openarchive\/#website","url":"https:\/\/www.nstda.or.th\/openarchive\/","name":"NSTDA Open Repository","description":"NSTDA Open Repository is a digital open-access repository for NSTDA&#039;s research publications, including manuscripts, journal articles conference papers, reviews, and more. The publications are made available in the Repository on terms of Creative Commons License. You may read, download, share, and re-use for your research as long as you abide by the license under which an item has been released.","publisher":{"@id":"https:\/\/www.nstda.or.th\/openarchive\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.nstda.or.th\/openarchive\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.nstda.or.th\/openarchive\/#organization","name":"National Science and Technology Development Agency","url":"https:\/\/www.nstda.or.th\/openarchive\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.nstda.or.th\/openarchive\/#\/schema\/logo\/image\/","url":"http:\/\/www.nstda.or.th\/openarchive\/wp-content\/uploads\/2019\/02\/cropped-cropped-aw-nstda-color-1-1.png","contentUrl":"http:\/\/www.nstda.or.th\/openarchive\/wp-content\/uploads\/2019\/02\/cropped-cropped-aw-nstda-color-1-1.png","width":2000,"height":625,"caption":"National Science and Technology Development Agency"},"image":{"@id":"https:\/\/www.nstda.or.th\/openarchive\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.nstda.or.th\/openarchive\/wp-json\/wp\/v2\/tnc_col_2494_item\/174333","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.nstda.or.th\/openarchive\/wp-json\/wp\/v2\/tnc_col_2494_item"}],"about":[{"href":"https:\/\/www.nstda.or.th\/openarchive\/wp-json\/wp\/v2\/types\/tnc_col_2494_item"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nstda.or.th\/openarchive\/wp-json\/wp\/v2\/comments?post=174333"}],"version-history":[{"count":1,"href":"https:\/\/www.nstda.or.th\/openarchive\/wp-json\/wp\/v2\/tnc_col_2494_item\/174333\/revisions"}],"predecessor-version":[{"id":174732,"href":"https:\/\/www.nstda.or.th\/openarchive\/wp-json\/wp\/v2\/tnc_col_2494_item\/174333\/revisions\/174732"}],"wp:attachment":[{"href":"https:\/\/www.nstda.or.th\/openarchive\/wp-json\/wp\/v2\/media?parent=174333"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}